Results 191 to 200 of about 42,511 (262)

Toxicokinetic modelling of the synthetic cannabinoid 5F‐MDMB‐P7AICA and its main metabolite in pigs following pulmonary administration

British Journal of Clinical Pharmacology, EarlyView.
Aims Since their emergence on the drug market, synthetic cannabinoids (SC) are still gaining increasing importance in forensic toxicology. The representatives of the so‐called new psychoactive substances have in common that they have not undergone preclinical safety studies. Hence, knowledge on toxicokinetic (TK) data is sparse.
Adrian A. Doerr, Christiane Dings, Omar Zaher, Frederike Nordmeier, Nadja Walle, Matthias W. Laschke, Michael D. Menger, Peter H. Schmidt, Markus R. Meyer, Thorsten Lehr, Nadine Schaefer   +10 more
wiley   +1 more source

Determination of Cortisol Levels in a Small Volume of Saliva of COVID-19-Recovering Patients During Treatment with Psychotropic Drugs. [PDF]

Biomedicines
Dziurkowska E, Guz-Rzeniecka G, Dziurkowski M.   +2 more
europepmc   +1 more source

Safety pharmacology of acute mescaline administration in healthy participants

British Journal of Clinical Pharmacology, EarlyView.
Aims Psychedelics, including mescaline, may serve as novel treatments for depression and anxiety. However, data is scarce on the safety of mescaline. Methods The present pooled analysis included two double‐blind, randomized, placebo‐controlled studies with a total of 48 participants and 96 mescaline administrations. Single oral‐dose administrations (n =
Aaron Klaiber, Mélusine Humbert‐Droz, Laura Ley, Yasmin Schmid, Matthias E. Liechti   +4 more
wiley   +1 more source

Sociodemographic and geographical variation in prescribing psychotropic drugs to children and young people with common mental disorders and Attention Deficit Hyperactive Disorders in North West London: population-based study. [PDF]

BMJ Open
Lazzarino AI, Naulls SR, Bakhti R, Hope S, Nicholls D, Otis M, Robinson T, Gnani S, Hargreaves DS.   +8 more
europepmc   +1 more source

Using sleep to enhance exposure treatment for anxious children: A pilot study

British Journal of Clinical Psychology, EarlyView.
Abstract Objectives: Exposure therapy is a well‐established treatment for anxiety disorders in children; however, many young people do not fully respond to treatment. Advances in strategies to enhance extinction learning from exposure therapy are urgently needed.
Ella L. Oar, Ronald M. Rapee, Cassie H. Lavell, Allison G. Harvey, Thomas H. Ollendick   +4 more
wiley   +1 more source

Anxiety, Depression, Schizophrenia, and Bipolar Disorder in Eosinophilic Esophagitis Patients: A Global Federated Cohort Analysis of Bidirectional Risks

Allergy, EarlyView.
Hui‐Chin Chang, Meng‐Che Wu, Torsten Zuberbier, Shuo‐Yan Gau   +3 more
wiley   +1 more source

An examination of core beliefs in generalized anxiety disorder

British Journal of Clinical Psychology, EarlyView.
Abstract Objective Generalised anxiety disorder (GAD) is characterised by uncontrollable worries. Cognitive behaviour therapy (CBT) is an effective treatment for GAD; however, manualised treatments rarely include interventions to target core beliefs. This study aimed to (1) explore the core beliefs about the self that are endorsed by individuals with ...
Amy E. Doust, Vesna Trenoska Basile, Sarah McDonald, Toby Newton‐John, Bethany M. Wootton   +4 more
wiley   +1 more source

Prescription of psychotropic drugs by non-psychiatrist specialists in Morocco: current practices and educational needs. [PDF]

BMC Med Educ
Bensouda Korachi I, Diouri I, Bouaddi O, Najdi A, Obtel M, Badou A, Belyamani L, Khalis M, Benjelloun R.   +8 more
europepmc   +1 more source

Psychotropic Drugs in Dermatology. Part 2: Antipsychotics, Sedative-Hypnotics and Anxiolytics in Dermatology.

Indian J Dermatol
Choudhary A, Bose S, Varsha KL, Madke B.
europepmc   +1 more source

Keep in mind sex differences when prescribing psychotropic drugs. [PDF]

World J Psychiatry
Mazza M, De Berardis D, Marano G.
europepmc   +1 more source